H.R. 4231In CommitteeHEALTH
Treat and Reduce Obesity Act of 2025
Key facts
Introduced: Jun 27, 2025
Chamber: House
Cosponsors: 77
Congress: 119th
Latest action · Jun 27, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Summary
Treat and Reduce Obesity Act of 2025
This bill expands Medicare coverage of intensive behavioral therapy for obesity. Specifically, the bill allows coverage for therapy that is provided by (1) a physician who is not a primary care physician; or (2) other health care providers (e.g., physician assistants and nurse practitioners) and approved counseling programs, if provided upon a referral from, and in coordination with, a physician or primary care practitioner. Currently, such therapy is covered only if provided by a primary care practitioner.
The bill also allows coverage under Medicare's prescription drug benefit of drugs used for the treatment of obesity or for weight loss management for individuals who are overweight.
Summary by Congressional Research Service.
Timeline
- Jun 27, 2025Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Jun 27, 2025Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Jun 27, 2025Introduced in House
- Jun 27, 2025Introduced in House
Cosponsors (showing first 30 of 77)
- Rep. Ruiz, Raul [D-CA-25] D-CA
- Rep. Miller-Meeks, Mariannette [R-IA-1] R-IA
- Rep. Moore, Gwen [D-WI-4] D-WI
- Rep. Panetta, Jimmy [D-CA-19] D-CA
- Rep. Fitzpatrick, Brian K. [R-PA-1] R-PA
- Rep. Boyle, Brendan F. [D-PA-2] D-PA
- Rep. Carey, Mike [R-OH-15] R-OH
- Rep. Thanedar, Shri [D-MI-13] D-MI
- Rep. Cohen, Steve [D-TN-9] D-TN
- Del. Norton, Eleanor Holmes [D-DC-At Large] D-DC
- Rep. Tlaib, Rashida [D-MI-12] D-MI
- Rep. Schweikert, David [R-AZ-1] R-AZ
- Rep. Larson, John B. [D-CT-1] D-CT
- Rep. Bacon, Don [R-NE-2] R-NE
- Rep. Figures, Shomari [D-AL-2] D-AL
- Rep. Thompson, Bennie G. [D-MS-2] D-MS
- Rep. Nadler, Jerrold [D-NY-12] D-NY
- Rep. Crow, Jason [D-CO-6] D-CO
- Rep. Beyer, Donald S. [D-VA-8] D-VA
- Rep. Mrvan, Frank J. [D-IN-1] D-IN
- Rep. Sewell, Terri A. [D-AL-7] D-AL
- Rep. Yakym, Rudy [R-IN-2] R-IN
- Rep. Conaway, Herbert C. [D-NJ-3] D-NJ
- Rep. Gonzalez, Vicente [D-TX-34] D-TX
- Rep. Waters, Maxine [D-CA-43] D-CA
- Rep. Carbajal, Salud O. [D-CA-24] D-CA
- Rep. Suozzi, Thomas R. [D-NY-3] D-NY
- Rep. Foster, Bill [D-IL-11] D-IL
- Rep. De La Cruz, Monica [R-TX-15] R-TX
- Rep. Matsui, Doris O. [D-CA-7] D-CA
In the News
- Novo Nordisk Ends Obesity Drug Lobbying Effort - Legis1
- Press Release: Rep. Mike Kelly Advocates for Enhanced Trade Laws to Support U.S. Steel Industry at Congressional Hearing - Quiver Quantitative
- Press Release: Mike Kelly Supports Passage of Whole Milk for Healthy Kids Act of 2025 | Stock News - Quiver Quantitative
- Press Release: Mike Kelly Applauds Trump Administration's Deal to Lower Costs of Weight Loss Drugs - Quiver Quantitative
- Lobbying Update: $80,000 of NOVO NORDISK INC. lobbying was just disclosed - Quiver Quantitative
- Congress Introduces Equity‑Driven Housing Bill to Close Homeownership Gap - The MortgagePoint
- ICYMI: Ranking Member Maxine Waters Honored with the National Low-Income Housing Coalition’s 2024 Policy Champion Award - House Financial Services Committee Democrats (.gov)
View official record on Congress.gov →